GlobeNewswire: Caerus Us 1 Inc. (dba Citeline) Contains the last 10 of 48 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T12:08:40ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/02/01/2822044/0/en/Introducing-Citeline-s-TrialScope-Disclose-Core-Data.html?f=22&fvtc=4&fvtv=28213Introducing Citeline’s TrialScope Disclose: Core Data2024-02-01T14:00:00Z<![CDATA[Clinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries Clinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries]]>https://www.globenewswire.com/news-release/2024/01/08/2805501/0/en/Citeline-to-Share-Exclusive-Insights-from-42nd-Annual-J-P-Morgan-Healthcare-Conference.html?f=22&fvtc=4&fvtv=28213Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare Conference2024-01-08T14:00:00Z<![CDATA[NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Citeline, a Norstella company providing robust data and expert business intelligence to the pharmaceutical industry, will offer exclusive access to insights from the 42nd Annual J.P. Morgan Healthcare Conference (JPM) Jan. 8–11, 2024 in San Francisco.]]>https://www.globenewswire.com/news-release/2023/07/13/2704425/0/en/Citeline-Appoints-Clinrol-as-Strategic-Clinical-Trial-Partner-Across-APAC-Region.html?f=22&fvtc=4&fvtv=28213Citeline Appoints Clinrol as Strategic Clinical Trial Partner Across APAC Region2023-07-13T13:12:00Z<![CDATA[NEW YORK, July 13, 2023 (GLOBE NEWSWIRE) -- Citeline, a global leader in clinical trial intelligence, has announced a strategic partnership with Clinrol, a clinical trial recruitment company, to expand and enhance patient recruitment for upcoming clinical trials across the Asia-Pacific (APAC) region. Clinrol is currently recruiting research participants in Australia for clinical trials in diabetes, cancer, dermatitis and other therapeutic areas.]]>https://www.globenewswire.com/news-release/2023/05/23/2674414/0/en/Introducing-Citeline-s-Sitetrove-Diversity-Module-Combining-Robust-Clinical-Investigator-and-Site-Intelligence-With-Patient-Demographics-to-Support-the-Diversification-of-Clinical-.html?f=22&fvtc=4&fvtv=28213Introducing Citeline’s Sitetrove Diversity Module, Combining Robust Clinical Investigator and Site Intelligence With Patient Demographics to Support the Diversification of Clinical Trials2023-05-23T13:01:00Z<![CDATA[NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” Citeline’s new Sitetrove Diversity Module marries robust site and investigator intelligence with patient age, race and gender data, enabling data-driven decision making to support the diversification of clinical trials.]]>https://www.globenewswire.com/news-release/2023/03/30/2637673/0/en/Citeline-Launches-TrialScope-Intelligence-Meeting-the-Growing-Complexities-of-Clinical-Trial-Disclosure.html?f=22&fvtc=4&fvtv=28213Citeline Launches TrialScope Intelligence, Meeting the Growing Complexities of Clinical Trial Disclosure2023-03-30T13:00:00Z<![CDATA[NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are feeling the pressure to maintain compliance, minimize risk and safeguard their brand reputation.]]>https://www.globenewswire.com/news-release/2023/02/22/2613289/0/en/Annual-Survey-of-Community-Pharmacists-in-the-UK-Reveals-Over-80-Considered-Leaving-Job-in-2022.html?f=22&fvtc=4&fvtv=28213Annual Survey of Community Pharmacists in the UK Reveals Over 80% Considered Leaving Job in 20222023-02-22T14:00:00Z<![CDATA[Workload, Stress Among Reasons Cited for Job Dissatisfaction Workload, Stress Among Reasons Cited for Job Dissatisfaction]]>https://www.globenewswire.com/news-release/2023/02/14/2607685/0/en/Primal-Pictures-and-the-Anatomical-Society-Partner-for-Medical-School-3D-Digital-Anatomy-Learning-Toolkit.html?f=22&fvtc=4&fvtv=28213Primal Pictures and the Anatomical Society Partner for Medical School 3D Digital Anatomy Learning Toolkit2023-02-14T14:00:00Z<![CDATA[The collaboration features explanatory videos, interactive models, clinical content & self-assessment exercises The collaboration features explanatory videos, interactive models, clinical content & self-assessment exercises]]>https://www.globenewswire.com/news-release/2023/01/31/2598539/0/en/Citeline-to-Unveil-Capabilities-of-New-Clinical-Trial-Workflow-Solution-at-SCOPE-2023-in-Orlando.html?f=22&fvtc=4&fvtv=28213Citeline to Unveil Capabilities of New Clinical Trial Workflow Solution at SCOPE 2023 in Orlando 2023-01-31T14:00:00Z<![CDATA[Next-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment Next-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment ]]>https://www.globenewswire.com/news-release/2022/11/09/2552141/0/en/Citeline-and-EMIS-Partner-to-Expand-Clinical-Trial-Access-in-the-UK.html?f=22&fvtc=4&fvtv=28213Citeline and EMIS Partner to Expand Clinical Trial Access in the UK2022-11-09T14:00:00Z<![CDATA[New alliance will boost access to clinical trials for thousands of individuals in the UK through their clinicians New alliance will boost access to clinical trials for thousands of individuals in the UK through their clinicians]]>https://www.globenewswire.com/news-release/2022/06/22/2467310/0/en/Pharma-Intelligence-Unveils-Its-Rebrand-to-Citeline-Following-Transition-to-Independent-Company.html?f=22&fvtc=4&fvtv=28213Pharma Intelligence Unveils Its Rebrand to Citeline Following Transition to Independent Company2022-06-22T14:30:00Z<![CDATA[New brand name Citeline reflects company transformation to focus on the global future of pharmaceutical and biopharmaceutical research New brand name Citeline reflects company transformation to focus on the global future of pharmaceutical and biopharmaceutical research]]>